ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: We demonstrate that LASP1 is specifically phosphorylated by BCR-ABL at tyrosine-171 in CML patients, which is abolished by tyrosine kinase inhibitor therapy.